The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia
Open accessAbstract
Black children with acute lymphoblastic leukemia (ALL) have poor outcomes, but limited information is available for children from other racial and ethnic backgrounds, such as Hispanic and Asian. We undertook a retrospective cohort study of children with ALL treated on Children's Cancer Group therapeutic protocols to determine outcomes by racial and ethnic backgrounds of patients treated with contemporary risk-based therapy. In total, 8447 children (white, n = 6703; Hispanic, n = 1071; black, n = 506; and Asian, n = 167) with newly diagnosed ALL between 1983 and 1995 were observed for a median of 6.5 years. Analysis of disease outcome was measured as overall survival (OS) and event-free survival (EFS) and was adjusted for known predictors of outcome including clinical features, disease biology, socioeconomic status, and treatment era (1983-1989 vs 1989-1995). There was a statistically significant difference in survival by ethnicity (P < .001). Five-year EFS rates were: Asian, 75.1% ± 3.5%; white, 72.8% ± 0.6%; Hispanic, 65.9% ± 1.5%; and black, 61.5% ± 2.2%. Multivariate analysis revealed that when compared with white children, black and Hispanic children had worse outcomes and Asian children had better outcomes after adjusting for known risk factors. The poorer outcomes among black children were most apparent among patients with standard-risk features (relative risk [RR], 2.0; 95% confidence interval [CI], 1.6-2.5), whereas poorer outcomes in Hispanic children (RR, 1.4; 95% CI, 1.2-1.6) were most evident among patients with high-risk features. Asian children had better outcomes than all racial and ethnic groups among high-risk patients, particularly in the recent era (5-year EFS, 90.9% ± 6.1%). Racial and ethnic differences in OS and EFS persist among children with ALL who receive contemporary risk-based therapy. Future studies should focus on reasons—perhaps compliance or pharmacogenetics—for those differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, ancestry, which is known to alter both pediatric ALL incidence and survival (Abrahão et al., 2015; Goggins & Lo, 2012; Linabery, Johnson, & Ross, 2012), is likely to also impact the risk and severity of late effects (Bhatia et al., 2002; Dores, Devesa, Curtis, Linet, & Morton, 2012; Lim, Bhatia, Robison, & Yang, 2014; Yang et al., 2010).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Bhatia et al., 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Modelling for Survival Data in Medical Research
(1995) · Technometrics · doi:10.1080/00401706.1995.10485920 · Cited by 2,159
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
(1999) · PsycEXTRA Dataset · doi:10.1037/e407432005-001 · Cited by 1,933
Pappas, G., Queen, S., Hadden, W., & Fisher, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290207 · Cited by 1,524
Modelling Survival Data in Medical Research
Collett, D. (1994) · Springer eBooks · doi:10.1007/978-1-4899-3115-3 · Cited by 1,064
Modelling Survival Data in Medical Research.
McLachlan, G. J., & Collett, D. (1994) · Biometrics · doi:10.2307/2533471 · Cited by 1,023
Smith, M. A., Arthur, D., Camitta, B. M., Carroll, A. J., Crist, W., Gaynon, P. S., Gelber, R. D., Heerema, N. A., Korn, E. L., Link, M. P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.18 · Cited by 892
Self-citation
Research works printed but not linked: 8
- Reaman, 1984, Racial variation in the frequency of immunological subtypes of childhood acute lymphoblastic leukemia., Prog Cancer Res Ther., 27, 163
- Sather, 1984, Differences in the presentation of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in black children and white children: a report from the Epidemiology Committee of the Children's Cancer Study Group., 179
- Falletta, 1984, Clinical and phenotypic features of childhood acute lymphocytic leukemia in whites, blacks, and Hispanics: a Pediatric Oncology Group study., Prog Cancer Res Ther., 27, 191
- Ries, 1999, SEER Cancer Statistics Review, 1973-1996.
- Hutchinson, 1996, Should therapy be intensified for patients with good risk ALL [abstract]?, Blood., 88, 668
- Lange, 1997, Double delayed intensification improves outcome in moderate risk pediatric acute lymphoblastic leukemia (ALL): a Children's Cancer Group study, CCG-1891 [abstract]., Blood., 90, 559
- Bostrom, 1998, Dexamethasone (DEX) decreases central nervous system (CNS) relapse and improves event-free survival (EFS) in lower risk acute lymphoblastic leukemia (ALL) [abstract]., Proc Am Soc Clin Oncol., 17, 527
- Kelsey, 1986, Methods in Observational Epidemiology: Retrospective Cohort Studies.
Cited by
Sorted by citations
Items 201–270 of 270
Isaac, E. I., Sivagnanalingam, U., Meisman, A. R., Donewar, C. W., Ewing, L. J., Katz, E. R., Muriel, A. C., & Rohan, J. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051581 · Cited by 5
Rovirosa, L., Ramos-Morales, A., & Javierre, B. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.592087 · Cited by 5
Chiabai, M. A., Lins, T. C. D. L., Pogue, R. E., & Pereira, R. W. (2012) · Disease Markers · doi:10.1155/2012/928940 · Cited by 5
IMPROVED OUTCOME IN SOUTH AFRICAN CHILDREN OF MIXED ETHNICITY TREATED FOR ALL
Dippenaar, A., Wessels, G., & Hesseling, P. B. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010600631979 · Cited by 4
Pombo‐de‐Oliveira, M. S., Córdoba, J. C., Alencar, D. M., Campos, M. M., Carriço, M. K., Dobbin, J., Dorea, M. D. F., Ferreira, R., Mendonça, N., & Magalhães, I. Q. (2005) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842005000100007 · Cited by 4
Wanderley, A. V., de Moraes, F. C. A., Nunes, G. G. D. C., Pereira, E. E. B., Leitão, L. P. C., de Oliveira, M. B., Tavares, Á. T. M., Pantoja, L. D. C., Khayat, B. C. M., Fernandes, M. R., et al. (2024) · Discover Oncology · doi:10.1007/s12672-024-01014-z · Cited by 3
Barakat, L. P., Scialla, M. A., Ramaswamy, N. S., Deatrick, J. A., Arasteh, K., Sandler, E. S., Hammer, S. N., & Kazak, A. E. (2026) · Implementation Science · doi:10.1186/s13012-026-01493-4 · Cited by 3
Leucemia linfoblástica aguda hiperdiploide en niños
Verduzco-Rodríguez, L., Verduzco-Aguirre, H. C., & López-Ariza, B. (2012) · Revista de Hematología · Cited by 3
Barragan, F., Mills, L. J., Raduski, A. R., Marcotte, E. L., Grinde, K. E., Spector, L. G., & Williams, L. A. (2022) · Cancer Medicine · doi:10.1002/cam4.5266 · Cited by 3
Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia
Pauly, M. G., & Silverman, L. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_17 · Cited by 3
Host factors and consequence of chemotherapy in pediatric cancer patients
Johnson, L. A., & Ross, J. A. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21630 · Cited by 3
Campana, D., & Pui, C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50105-6 · Cited by 4
Childhood Acute Lymphoblastic Leukaemia
Liang, D., & Pui, C. (2005) · Wiley eBooks · doi:10.1002/9780470987056.ch33 · Cited by 3
Genetic Ancestry and Childhood Acute Lymphoblastic Leukemia Subtypes and Outcomes in the Genomic Era
Rabin, K. R. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6785 · Cited by 3
Ligon, J. A., Ji, L., Dang, A., Xu, X., Rheingold, S. R., Bhojwani, D., Devidas, M., Kairalla, J. A., Shago, M., Heerema, N. A., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025016670 · Cited by 2
Self-citationAcute lymphoblastic leukemia: an update on treatment and Brazilian perspective
Correa, B. T., Silva, G. S. S., Mendes, W. J. S., Soares, L. L., Lima, J. A., Pereira, C. G. S., de Souza, J. V. T., dos Santos, M. E. F., Aleluia, A. C. M., da Guarda, C. C., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1637924 · Cited by 2
Hispanic Ethnicity and the Risk of Pediatric Leukemia Relapse
Amankwah, E. K., & Hale, G. A. (2017) · Clinical Pediatrics · doi:10.1177/0009922817732147 · Cited by 2
Gilbert, J. R., Sabnis, H. S., Radzievski, R., Doxie, D. B., DeRyckere, D., Castellino, S. M., & Dhodapkar, K. M. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004774 · Cited by 2
Advancing the Science of Cancer in Latinos
Ramírez, A. G., & Trapido, E. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-14436-3 · Cited by 2
Establishing an HSCT Program with Limited Resources
Nassar, A., Srivastava, A., Hashmi, S. K., & Aljurf, M. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-59358-6_18 · Cited by 2
Moradi, G., Rasouli, M. A., Fathi, F., Ghaderi, B., Nikkhoo, B., Roshani, D., Moradvaisi, B., & Soltani, J. (2018) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.29252/sjku.23.2.12 · Cited by 2
Horn, B. N., Lamba, N., Chellapandian, D., Sunkersett, G., Silva, J. G., Ziga, E. D., Alperstein, W., Joyce, M., Castillo, P., Fort, J. A., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29180 · Cited by 2
Childhood Outcome Disparities in Cancer Care
Renner, L. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-71113-9_5-1 · Cited by 2
Survival of Patients with Acute Lymphoblastic Leukemia
Organista‐Nava, J., Gómez‐Gómez, Y., Illades‐Aguiar, B., & Antônio, M. (2013) · InTech eBooks · doi:10.5772/54261 · Cited by 2
Frequency and types of chromosomal abnormalities in acute lymphoblastic leukemia patients in Turkey
Demirhana, O., Tanrıverdia, N., & Süleymanovaa, D. (2019) · Archives of Community Medicine and Public Health · doi:10.17352/2455-5479.000055 · Cited by 2
Elhasid, R., Nirel, R., Avigad, S., Avrahami, G., Abramov, A., Attias, D., Arad, N., Ballin, A., Arush, M. W. B., Bielorai, B., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28024 · Cited by 2
Associations between race and survival in pediatric patients with diffuse large B‐cell lymphoma
Khullar, K., Plascak, J. J., Drachtman, R. A., Cole, P. D., & Parikh, R. R. (2021) · Cancer Medicine · doi:10.1002/cam4.3736 · Cited by 2
Childhood Acute Lymphoblastic Leukemia
Rashed, W. M., & Elhadad, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00004-4 · Cited by 2
Zachman, D. K., Bardahl, J. G., Graves, L. A., & Wagner, L. M. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.31355 · Cited by 1
Romo, S., Macias, A., Rohan, J. M., Jones, H. A., & Corona, R. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31911 · Cited by 1
Kenan, R. F. B., Retson, L., Fodor, B., Temkit, M., & Walsh, A. M. (2026) · Cancer Medicine · doi:10.1002/cam4.71719 · Cited by 1
Kumar, N. V., Nataraj, S., Kornher, K., Real, M., Love, B. D., Morales, J., Perdomo, B. P., Thornburg, C. D., & Aristizabal, P. (2026) · Pediatric Blood & Cancer · doi:10.1002/1545-5017.70246 · Cited by 1
Mourad, Y. R. A., Bhargava, R., Bruyèrè, H., Gillian, T., Barnett, M. J., Forrest, D. L., Nevill, T. J., Toze, C. L., Nantel, S. H., & Shepherd, J. D. (2012) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2012.09.007 · Cited by 1
Brown, A. L., Raghubar, K. P., Scheurer, M. E., & Lupo, P. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-14436-3_4 · Cited by 1
Epidemiology of malignant neoplasms in young children in the Kyrgyz Republic
Макимбетов, Э. К., Talgat, T. U., Sorokin, A. A., Amankulov, A. А., Тиллоев, Т. A., & Mamashov, N. M. (2024) · Russian Journal of Pediatric Hematology and Oncology · doi:10.21682/2311-1267-2024-11-2-54-60 · Cited by 1
Shariff, N., Foo, J. C., Parsons, S. K., & Hodgson, D. C. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2531154 · Cited by 1
O'Connor, T. E., Lin, C., Roloff, G. W., Zhang, A., Miller, K., Aldoss, I. T., Kopmar, N. E., Dekker, S. E., Gupta, V. K., Jeyakumar, N., et al. (2025) · Bone Marrow Transplantation · doi:10.1038/s41409-025-02693-0 · Cited by 1
Treatment of Pediatric B- and T-Cell Acute Lymphoblastic Leukemia
Hogan, L. E., Maese, L. D., August, K. J., & McNeer, J. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-85147-7_4 · Cited by 1
Zupanec, S., & Tomlinson, D. (2010) · Pediatric oncology · doi:10.1007/978-3-540-87984-8_1 · Cited by 1
Racial and Ethnic Factors in Outcomes of Children With Acute Lymphoblastic Leukemia
Ruiz-Argüelles, G. J. (2004) · JAMA · doi:10.1001/jama.291.21.2541-a
Genetic and epigenetic characterization of pediatric high hyperdiploid acute lymphoblastic leukemia
Davidsson, J. (2009) · Lund University Publications (Lund University)
Estlin, E. J., & Kane, J. R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48007-7_5
Schapkaitz, E. (2009) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Jobayer, H., & Xie, L. (2014) · Journal of Public Health and Epidemiology · doi:10.5897/jphe2014.0627
Bailey‐Olson, M., Cowan, M. J., Dvorak, C. C., Mueller, S., Owens, A., Wahlstrom, J. T., & Horn, B. N. (2016) · Journal of Pediatric Oncology Nursing · doi:10.1177/1043454216631509
Advances in prognostication and treatment of pediatric acute leukemia
Chaleff, S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781292.019
BIDIL: A RACE-TARGETED DRUG FOR BLACK AMERICAN’S ONLY
Talniya, N. C. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i11.20022
Wang, L. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3cn6z72s
Racial Differences in Rates of Traumatic Lumbar Puncture
Vachon, G. C. (2003) · JAMA · doi:10.1001/jama.289.5.548
Shahverdi, E., Karami, P., Tavakoli, F., Maki, M., Moazzami, M., Feizi, F., Salamati, P., Lotfipour, A., & Ehsani, M. A. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.30476/mejc.2019.81253.0
Frecuencia de cromosoma Filadelfia en niños con leucemia linfoblástica aguda
Hernández-Alcaraz, M., & Dueñas-Arias, J. E. (2020) · Revista Mexicana de Pediatría · doi:10.35366/97170
Racial Differences in Rates of Traumatic Lumbar Puncture—Reply
Howard, S. C., de Armendi, A. J., & Pui, C. (2003) · JAMA · doi:10.1001/jama.289.5.548-b
Current Awareness in Hematological Oncology
(2003) · Hematological Oncology · doi:10.1002/hon.706
Mkhwanazi, Z. A., Mfusi, S. A., & Nkambule, B. B. (2022) · Medicine · doi:10.1097/md.0000000000028868
T-cell lymphoblastic leukaemia: The Johannesburg state-sector experience
Vaughan, J., Wiggill, T. M., Willem, P., & Hodkinson, K. E. (2022) · South African Journal of Oncology · doi:10.4102/sajo.v6i0.229
Breastfeeding and acute lymphoblastic leukemia in a middle-income country: a Mexican perspective
Mancías‐Guerra, C., Nuño-Vázquez, L., Gutiérrez‐Aguirre, C. H., Cantú‐Rodríguez, O. G., Fierro-Sáenz, S., Velasco-Ruiz, I., Colunga‐Pedraza, J. E., Jimenez-Antolinez, Y. V., & González‐Llano, Ó. (2023) · Medicina Universitaria · doi:10.24875/rmu.22000077
Causal Mediation Analysis for Childhood Cancer Survival Disparity in Texas, 2005 to 2014
Morshed, N., Russell, W., & Benjamin Zhan, F. (2024) · Journal of Community Medicine and Health Solutions · doi:10.29328/journal.jcmhs.1001044
Shoag, J. M., Li, Y., Getz, K., Huang, Y.-S. V., Hall, M., Naranjo, A. H., Richardson, T., Desai, A. V., Umaretiya, P. J., Aziz‐Bose, R., et al. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.31192
Childhood Outcome Disparities in Cancer Care
Renner, L. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-76882-8_5
Algiraigri, A. H. (2025) · Journal of Applied Hematology · doi:10.4103/joah.joah_74_25
Palet, J. E. K. K., Nguinzanemou, C. J. K., Kango, S. C., Anguize, B., Tou, R. R. E. G. Y. Z., Bangue, M. C. N., Ouaïmon, D. S., Maka, E. T. E., Mejiozem, O. B. B., Yanza, M. C. A. S., et al. (2025) · Journal of Cancer Therapy · doi:10.4236/jct.2025.1610028
FIGURE 2 in On four new canopy spiders of Dictynidae (Araneae) from Xishuangbanna Rainforest, China
Zhang, Z.-S., & Li, S. (2011) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.201344
Ding, L., Szymczak, J. E., Evans, E., Canepa, E., Martin, A. E., Contractor, F., Aplenc, R., Joseph, G., & Winestone, L. E. (2022) · Figshare · doi:10.6084/m9.figshare.19759449
A meta-analysis and expression profiling of DNA repair gene polymorphisms in leukemia
Ye, H., Fang, J., & Jin, P. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1777198
Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000–2019
dos Reis, D. T., Silvestri, E. F., Oliveira, E. J. F., Chiedde, M., Santos, E. F. D. S., Macedo, H., Koike, M. K., & Calderon, M. G. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2691908
From ANC Oscillations Towards an Improved Childhood ALL Maintenance Therapy
Säger, S., Gebhard, A., Metzler, M., Rauh, M., Schmiegelow, K., Toksvang, L. N., & Zierk, J. (2026) · Quantitative Medicine · doi:10.70534/qm-2026-0010
Pediatric Oncology Clinical Trial Participation Among Families From Historically Marginalized Groups
Umaretiya, P. J., Paul, M. A., Valenzuela, A., Hawkins, A., Revette, A. C., Nava‐Coulter, B., Eche, I. J., Snaman, J. M., Aziz‐Bose, R., Kelly, C. A., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.26538
OPTIMIZATION OF TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA AT TEENAGERS IN AZERBAIJAN
Багиров, И. A., Острого, О. Л., Лейкоза, Л., Подростков, У., Азербайджане, В., & И.A, Б. (2013) · CyberLeninK (CyberLeninka)
Metadata
- Authors
- Bhatia, S., Sather, H. N., Heerema, N. A., Trigg, M. E., Gaynon, P. S., & Robison, L. L.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Bhatia, Smita
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-09-15
- Volume
- 100
- Issue
- 6
- Pages
- 1957-1964
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1995246501
- Cited by
- 270
- References
- 47
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 9 · 2023: 11 · 2022: 15 · 2021: 14 · 2020: 25 · 2019: 12 · 2018: 11 · 2017: 12 · 2016: 13 · 2015: 12 · 2014: 18 · 2013: 10 · 2012: 17
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (U10CA013539, 5U10 CA 13539-2652)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- acute lymphoblastic leukemia, racial disparities, ethnic differences, children, overall survival, event-free survival, Hispanic children, Black children, Asian children, socioeconomic status, pharmacogenetics, medication adherence
- MeSH terms
- Adolescent, Child, Child, Preschool, Chromosome Aberrations, Ethnicity, Female, Follow-Up Studies, Humans, Infant, Male, Prospective Studies, Retrospective Studies, Risk Factors, Social Class, Survival Analysis, Treatment Outcome, Disease-Free Survival, Racial Groups, Precursor Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review